Humedix Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 20.79%

Humedix Co Ltd (200670) has an Asset Resilience Ratio of 20.79% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore Humedix Co Ltd total assets for the complete picture of this company's asset base.

Liquid Assets

₩60.00 Billion
≈ $40.66 Million USD Cash + Short-term Investments

Total Assets

₩288.63 Billion
≈ $195.60 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Humedix Co Ltd's Asset Resilience Ratio has changed over time. See how leveraged is Humedix Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Humedix Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Humedix Co Ltd worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩60.00 Billion 20.79%
Total Liquid Assets ₩60.00 Billion 20.79%

Asset Resilience Insights

  • Good Liquidity Position: Humedix Co Ltd maintains a healthy 20.79% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Humedix Co Ltd Industry Peers by Asset Resilience Ratio

Compare Humedix Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
Drug Manufacturers - Specialty & Generic 0.16%
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Ajanta Pharma Limited
NSE:AJANTPHARM
Drug Manufacturers - Specialty & Generic 14.99%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%
Guizhou Bailing Group Pharmaceutical Co Ltd
SHE:002424
Drug Manufacturers - Specialty & Generic 2.09%
Dezhan HealthCare Co Ltd
SHE:000813
Drug Manufacturers - Specialty & Generic 0.15%

Annual Asset Resilience Ratio for Humedix Co Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Humedix Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 31.56% ₩78.82 Billion
≈ $53.42 Million
₩249.75 Billion
≈ $169.25 Million
+4.28pp
2023-12-31 27.28% ₩60.00 Billion
≈ $40.66 Million
₩219.98 Billion
≈ $149.08 Million
-7.95pp
2022-12-31 35.23% ₩80.01 Billion
≈ $54.22 Million
₩227.14 Billion
≈ $153.93 Million
+10.05pp
2021-12-31 25.18% ₩54.35 Billion
≈ $36.83 Million
₩215.86 Billion
≈ $146.29 Million
+0.33pp
2020-12-31 24.85% ₩43.66 Billion
≈ $29.59 Million
₩175.65 Billion
≈ $119.03 Million
+10.84pp
2019-12-31 14.02% ₩19.41 Billion
≈ $13.15 Million
₩138.42 Billion
≈ $93.81 Million
-9.32pp
2018-12-31 23.34% ₩29.94 Billion
≈ $20.29 Million
₩128.28 Billion
≈ $86.93 Million
-6.00pp
2017-12-31 29.34% ₩38.06 Billion
≈ $25.79 Million
₩129.74 Billion
≈ $87.92 Million
-16.31pp
2016-12-31 45.64% ₩59.86 Billion
≈ $40.57 Million
₩131.16 Billion
≈ $88.88 Million
+45.42pp
2015-12-31 0.22% ₩252.88 Million
≈ $171.37K
₩115.90 Billion
≈ $78.54 Million
--
pp = percentage points

About Humedix Co Ltd

KQ:200670 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$200.07 Million
₩295.22 Billion KRW
Market Cap Rank
#16648 Global
#664 in Korea
Share Price
₩28700.00
Change (1 day)
-1.71%
52-Week Range
₩28700.00 - ₩75800.00
All Time High
₩75800.00
About

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to H… Read more